BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23836088)

  • 1. Opioid induced bowel disease: a twenty-first century physicians' dilemma. Considering pathophysiology and treatment strategies.
    Sharma A; Jamal MM
    Curr Gastroenterol Rep; 2013 Jul; 15(7):334. PubMed ID: 23836088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction.
    Leppert W
    Drug Des Devel Ther; 2015; 9():2215-31. PubMed ID: 25931815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction-Recommendations of the Nordic Working Group.
    Drewes AM; Munkholm P; Simrén M; Breivik H; Kongsgaard UE; Hatlebakk JG; Agreus L; Friedrichsen M; Christrup LL
    Scand J Pain; 2016 Apr; 11():111-122. PubMed ID: 28850449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
    Holder RM; Rhee D
    Pharmacotherapy; 2016 Mar; 36(3):287-99. PubMed ID: 26945548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid-induced bowel dysfunction: pathophysiology and management.
    Brock C; Olesen SS; Olesen AE; Frøkjaer JB; Andresen T; Drewes AM
    Drugs; 2012 Oct; 72(14):1847-65. PubMed ID: 22950533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on the use of pharmacotherapy for opioid-induced bowel dysfunction.
    Mousavi T; Nikfar S; Abdollahi M
    Expert Opin Pharmacother; 2023 Feb; 24(3):359-375. PubMed ID: 36548911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mu-opioid antagonists for opioid-induced bowel dysfunction.
    McNicol ED; Boyce D; Schumann R; Carr DB
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006332. PubMed ID: 18425947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid-induced constipation in chronic noncancer pain.
    Weber HC
    Curr Opin Endocrinol Diabetes Obes; 2016 Feb; 23(1):11-7. PubMed ID: 26702846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis.
    Nee J; Zakari M; Sugarman MA; Whelan J; Hirsch W; Sultan S; Ballou S; Iturrino J; Lembo A
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1569-1584.e2. PubMed ID: 29374616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review.
    Leppert W
    Adv Ther; 2010 Oct; 27(10):714-30. PubMed ID: 20799006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, prevalence, and management of opioid bowel dysfunction.
    Pappagallo M
    Am J Surg; 2001 Nov; 182(5A Suppl):11S-18S. PubMed ID: 11755892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, placebo-controlled phase 3 trial (Study SB-767905/013) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.
    Irving G; Pénzes J; Ramjattan B; Cousins M; Rauck R; Spierings EL; Kleoudis CS; Snidow JW; Pierce A; Wurzelmann J; Mortensen ER
    J Pain; 2011 Feb; 12(2):175-84. PubMed ID: 21292168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the potential role of methylnaltrexone in opioid bowel dysfunction.
    Foss JF
    Am J Surg; 2001 Nov; 182(5A Suppl):19S-26S. PubMed ID: 11755893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain.
    Webster L; Jansen JP; Peppin J; Lasko B; Irving G; Morlion B; Snidow J; Pierce A; Mortensen E; Kleoudis C; Carter E
    Pain; 2008 Jul; 137(2):428-440. PubMed ID: 18164818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid-induced bowel dysfunction.
    Ketwaroo GA; Cheng V; Lembo A
    Curr Gastroenterol Rep; 2013 Sep; 15(9):344. PubMed ID: 23900996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approaches to the treatment of opioid-induced constipation.
    Holzer P
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1(0 1):119-27. PubMed ID: 18924451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylnaltrexone bromide: new drug for the treatment of opioid-induced bowel dysfunction.
    Baker DE
    Rev Gastroenterol Disord; 2009; 9(3):E84-93. PubMed ID: 19898269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review with meta-analysis: efficacy and safety of treatments for opioid-induced constipation.
    Vijayvargiya P; Camilleri M; Vijayvargiya P; Erwin P; Murad MH
    Aliment Pharmacol Ther; 2020 Jul; 52(1):37-53. PubMed ID: 32462777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of opioid analgesics on the gastrointestinal tract function and the current management possibilities.
    Leppert W
    Contemp Oncol (Pozn); 2012; 16(2):125-31. PubMed ID: 23788866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
    Chamberlain BH; Cross K; Winston JL; Thomas J; Wang W; Su C; Israel RJ
    J Pain Symptom Manage; 2009 Nov; 38(5):683-90. PubMed ID: 19713070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.